Management of hepatitis B and C in special population

Anand V Kulkarni1, Nageshwar Reddy Duvvuru2

  • 1Department of Hepatology, Asian Institute of Gastroenterology, Hyderabad 500032, Telangana, India. anandvk90@gmail.com.

Insights

New oral antiviral therapies offer effective treatment for chronic hepatitis B (CHB) and chronic hepatitis C (CHC). This review examines their use in special populations, including those with kidney disease and pregnant women.

Area of Science:

  • Hepatology
  • Virology
  • Pharmacology

Background:

  • Chronic viral hepatitis B and C are major global causes of cirrhosis.
  • Hepatitis B is prevalent in the Asia-Pacific, while Hepatitis C is more common in the West.
  • Recent advancements include oral direct-acting antivirals (DAAs) for CHC and nucleos(t)ide analogs (NUCs) for CHB.

Purpose of the Study:

  • To review the management of chronic hepatitis B and C in special patient populations.
  • To discuss the evolving safety and efficacy data of oral antiviral therapies in these groups.

Main Methods:

  • Literature review of current clinical guidelines and research.
  • Analysis of treatment outcomes and safety profiles in specific populations.

Main Results:

  • Oral DAAs and NUCs demonstrate high efficacy, good tolerability, and low resistance rates.
  • Robust data is lacking for certain special populations, requiring ongoing research.

Conclusions:

  • Oral antiviral therapies have revolutionized CHB and CHC management.
  • Further investigation is needed to optimize treatment strategies for special populations, including those with chronic kidney disease, pregnant women, healthcare workers, and immunocompromised individuals.

Related Concept Videos

Standard Precaution01:26

Standard Precaution

Standard precautions are the minimum infection control safeguards used while caring for all patients, irrespective of their disease condition. They help prevent the spread of common infectious microorganisms to healthcare workers, patients, and visitors in all healthcare settings.
Hand hygiene is the most crucial means to prevent the transmission of disease. Employers are legally required to provide their workers with personal protective equipment (PPE) to minimize exposure or contact with...
2.3K
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
393
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol...
173
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
19
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
21
Transmission-based Precautions I: Contact, Enteric, and Droplets01:17

Transmission-based Precautions I: Contact, Enteric, and Droplets

Transmission-based precautions are for patients known to be infected or suspected to be infected or colonized with organisms that pose a significant risk to others. Some transmission-based precautions include contact, enteric, and droplet.
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...
4.2K